Phase II study of axitinib for downstaging cT2a to cT1 renal tumors for allowing partial nephrectomy (AXIPAN).
Jean-Jacques Patard
(1)
,
Jean-Christophe Bernard
,
Karim Bensalah
(2, 3)
,
Hervé Baumert
(4)
,
Hervé Lang
(5)
,
Didier Jacqmin
(6)
,
Brigitte Duclos
,
Alain Ravaud
,
Brigitte Laguerre
(7)
,
Laurence Albiges
(8)
,
Armelle Arnoux
,
Bernard Escudier
(8)
Jean-Christophe Bernard
- Function : Author
Brigitte Duclos
- Function : Author
Alain Ravaud
- Function : Author
- PersonId : 759830
- ORCID : 0000-0001-9455-6744
- IdRef : 058504710
Armelle Arnoux
- Function : Author
- PersonId : 1198462
- IdHAL : armelle-guenegou-arnoux
Bernard Escudier
- Function : Author
- PersonId : 907541
Abstract
no abstract